▶2h 3m
WebinarDemo archive
Hematocrit Monitoring in Testosterone Therapy
Dr. Neal Rouzier
3 chapters · Testosterone & Cardiovascular Risk
Topics / Men's Hormone Health
Testosterone & Cardiovascular Risk
Evidence on testosterone therapy and cardiovascular outcomes — a recurring controversy in hormone medicine.
Dr. Rouzier's teaching
Webinars and commentary
Start here for Dr. Rouzier's perspective on Testosterone & Cardiovascular Risk. Supporting published studies follow below.
Supporting evidence
Highest quality evidence
Published studies tagged to Testosterone & Cardiovascular Risk, ordered by evidence strength. Inspect design and limitations before applying findings.
International journal of impotence research2022PMID 34999717
Testosterone replacement therapy and cardiovascular disease.
Contemporary evidence does not support the historical concern that testosterone replacement therapy broadly increases cardiovascular risk in appropriately selected men; benefits and risks depend on indication, formulation, monitoring, and baseline cardiovascular status.
ReviewEvidence: ModerateRelevance: HighRouzier commentary
Recent studies
2022Evidence: Moderate
Testosterone replacement therapy and cardiovascular disease.
International journal of impotence research
Contemporary evidence does not support the historical concern that testosterone replacement therapy broadly increases cardiovascular risk in appropriately selected men; benefits and risks depend on indication, formulation, monitoring, and baseline cardiovascular status.